M

MannKind Corp
D

MNKD

5.00000
USD
0.02
(0.40%)
مغلق
حجم التداول
74,657
الربح لكل سهم
0
العائد الربحي
-
P/E
50
حجم السوق
1,517,956,720
أصول ذات صلة
ABBV
ABBV
2.480
(1.16%)
216.670 USD
A
ACAD
-0.355
(-2.02%)
17.190 USD
A
ACRS
-0.19000
(-10.44%)
1.63000 USD
A
ADAP
-0.04520
(-9.13%)
0.45000 USD
A
AGIO
-0.360
(-1.11%)
31.990 USD
ALNY
ALNY
-11.390
(-4.66%)
233.090 USD
AMGN
AMGN
2.35
(0.72%)
327.22 USD
A
AMRN
-0.06700
(-12.64%)
0.46300 USD
A
ASMB
-0.080
(-0.72%)
11.000 USD
A
ATNM
-0.03500
(-3.07%)
1.10500 USD
B
BHC
-0.12000
(-1.68%)
7.02500 USD
BMY
BMY
2.050
(3.36%)
63.140 USD
C
CARA
0.02000
(0.41%)
4.95000 USD
C
CGEN
-0.05500
(-3.35%)
1.58500 USD
C
CRBP
0.02500
(0.37%)
6.80500 USD
C
CRIS
-0.12000
(-4.12%)
2.79000 USD
C
CRSP
-2.160
(-4.75%)
43.340 USD
D
DVAX
0.010
(0.07%)
14.400 USD
E
EXEL
0.550
(1.43%)
39.140 USD
F
FATE
-0.06000
(-6.00%)
0.94000 USD
F
FGEN
0.00710
(1.91%)
0.37880 USD
F
FOLD
-0.21000
(-2.37%)
8.64000 USD
G
GERN
-0.10500
(-6.09%)
1.62000 USD
G
GLPG
-0.750
(-2.82%)
25.820 USD
INCY
INCY
0.410
(0.58%)
71.140 USD
I
IOVA
-0.00500
(-0.13%)
3.74000 USD
I
ITCI
0.000
(0.00%)
131.260 USD
K
KALA
-0.40000
(-5.52%)
6.84000 USD
K
KPTI
0.83000
(12.06%)
7.71000 USD
N
NKTR
-0.03600
(-4.16%)
0.82920 USD
N
NVCR
0.110
(0.55%)
20.290 USD
O
OMER
-0.61000
(-7.97%)
7.04000 USD
O
ORMP
-0.07000
(-2.70%)
2.52000 USD
PFE
PFE
-0.070
(-0.26%)
26.660 USD
P
PRTA
-0.640
(-4.19%)
14.620 USD
Q
QURE
-0.490
(-4.01%)
11.740 USD
R
RIGL
-0.910
(-4.43%)
19.630 USD
S
SRRK
-0.870
(-2.41%)
35.170 USD
T
TBPH
-0.06000
(-0.63%)
9.48000 USD
T
TGTX
0.810
(2.11%)
39.260 USD
V
VERU
-0.00510
(-1.00%)
0.50610 USD
V
VSTM
0.10000
(1.43%)
7.09000 USD
X
XNCR
-0.230
(-1.66%)
13.640 USD
المزيد
الأخبار المقالات

العنوان: MannKind Corp

القطاع: Healthcare
الصناعة: Biotechnology
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.